Industry news

• Russia has created a center to ensure the availability of innovative technologies in the CIS countries

  31 October 2022 GxPnews

  The Center for Ensuring the Availability of Innovative Technologies, Quality Control and Enhanced Effectiveness of Medical Care Financing in the CIS countries was established in Russia. This was reported in the Federal State Budgetary Institution CEQCMC of the Ministry of Health of Russia.

• Pharmasynthesis intends to launch pharmaceutical production in Tajikistan

  27 October 2022 GxPnews

  Rajabboy Ahmadzoda, the head of the Sughd Province of Tajikistan, and Grigory Demidov, the head of international projects in Russia’s Pharmasynthesis company, discussed the implementation of a project to establish drug production in the region, as the press service of the head of the region reports.

• Import-substituting production of an antibiotic for veterinary use will begin in Tomsk in 2022

  27 October 2022 GxPnews

  The Tomsk company has launched a new production line for the production of an antibiotic for farm livestock and pets, which was previously imported. This was reported by the press service of the Tomsk Region administration.

• The first Russian generic for hemochromatosis therapy has been registered

  27 October 2022 GxPnews

  In October 2022, PSK Pharma received a registration certificate for Deferasirox PSK in the form of dispersible tablets in three dosages: 125 mg, 250 mg, and 500 mg. This product became the first fully Russian dispersible drug with deferasirox as the active substance for the treatment of iron poisoning. This is reported on the official website of Rus Biopharm group of companies.

• The Ministry of Health has registered a new oral contraceptive with native estrogen

  26 October 2022 GxPnews

  The Ministry of Health of the Russian Federation has registered Gedeon Richter’s combined oral contraceptive (COC) under trade name Esteretta. The drug is a combination of estetrol and drospirenone. This was reported in the press service of the company.

• The Ministry of Health of the Russian Federation approved the trial of the vaccine against Marburg fever

  26 October 2022 GxPnews

  The Ministry of Health of the Russian Federation has issued a permit for trials of the FiloPan vaccine for the prevention of infections caused by Marburg and Ebola viruses, FV reports, referring to data from the State Register of Medicines (GRLS). Phase 1 of the clinical trial is intended to test the safety, tolerability, and immunogenicity of the drug in adult volunteers.

• The Ministry of Health has registered a new oral contraceptive with native estrogen

  25 October 2022 GxPnews

  The Ministry of Health of the Russian Federation has registered Gedeon Richter’s combined oral contraceptive (COC) under trade name Esteretta. The drug is a combination of estetrol and drospirenone. This was reported in the press service of the company.

• A new drug has become available for Russian patients with chronic kidney disease

  25 October 2022 GxPnews

  PSK Pharma has announced the release of a new domestic drug Sevelamer (Sevella) for the treatment of chronic kidney disease (CKD). The drug is included in the list of vital and essential drugs (VED) approved by the Government of the Russian Federation.

• First patient receives novel, potentially cancer-stopping pill

  24 October 2022 Izzy Wood / European Pharmaceutical Review

  City of Hope, one of the largest cancer research and treatment organisations in the US, announced that the first patient to receive novel cancer medicine AOH1996, is doing well.

• The Ministry of Health has denied the decrease in the number of clinical trials of drugs in Russia

  24 October 2022 GxPnews

  The number of clinical trials of drugs in the Russian Federation is stable and is not decreasing. This is reported by TASS with reference to the press service of the Ministry of Health of the Russian Federation.